IRAK inhibitor 4 (trans)
IRAK inhibitor 4 (trans) is the trans form of IRAK inhibitor 4. IRAK inhibitor 4 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor.
Product Specifications
CAS Number
[2070014-89-8]
UNSPSC
12352005
Target
IRAK
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/IRAK-inhibitor-4-trans.html
Purity
99.02
Solubility
DMSO : ≥ 38 mg/mL
Smiles
O=C(C1=CC=C2C(N=C(NC3=NNC4=C3C=C(C5=CC=CC=C5OC(F)(F)F)C=C4)N2[C@@H]6CC[C@@H](O)CC6)=C1)NCCC(C)C
Molecular Formula
C33H35F3N6O3
Molecular Weight
620.66
References & Citations
[1]Indazole derivatives as modulators of interleukin-1 receptor-associated kinase. Patent WO 2008030584 A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IRAK4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
R0495-10E-ML650 100 µL
Raf, phosphorylated (Ser338, Tyr340) (Raf1, c-Raf) (MaxLight 650) discontinued
Ask
View Details 